Delivery Order SPE2DB22D2006-SPE2DB25FW0UJ
- Not listed
- The Defense Logistics Agency awarded a $6,702.75 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for Botox Cosmetic 100 Unit Vials with an ultimate completion date of September 17, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of BOTOX Cosmetic 100 Unit Vials, valued at $3,574.80 with a completion date of September 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $5,191.32 delivery order to AmerisourceBergen Drug Corp for Botox Cosmetic 100 unit vials. The contract carries a firm fixed price structure with no set-aside designation and is scheduled for completion by December 12, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026, which serves as the primary vehicle...
- The Defense Logistics Agency awarded a $3,936.00 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Botox Cosmetic under firm fixed price terms. The order, which was competitively awarded without a set-aside designation, is scheduled for completion by May 27, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Botox Cosmetic 100 Unit Vials with a ceiling value of $2,234.25. This is a firm fixed price delivery order with no set-aside designation, completed on a competitive basis. The contract was awarded to AmerisourceBergen's Corporate Office division, located in Conshohocken, Pennsylvania, which also serves as the place of performance. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $10,257.48 delivery order to AmerisourceBergen Drug Corp for BOTOX 200 unit vials on July 28, 2025, with an ultimate completion date of August 18, 2025. This is a firm fixed price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026,...
- The Defense Logistics Agency awarded a $3,574.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BOTOX Cosmetic 100 Unit Vials, with an ultimate completion date of September 30, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,419.20 for 200-unit vials of BOTOX on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999...
- The Defense Logistics Agency awarded a delivery order valued at $10,336.32 to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX on May 27, 2025, with completion targeted for June 17, 2025. This is a firm fixed-price delivery order under a non-competitive set-aside arrangement, performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor in the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of BOTOX 100 unit vials with a ceiling value of $1,722.72. This firm fixed price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 25, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW0UJDelivery Order
The Defense Logistics Agency awarded a $6,560 delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of BOTOX Cosmetic 100 Unit Vials with a completion date of June 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. As the prime contractor on the DLA Troop Support Medical IDC, the company supplies a comprehensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. The company's demonstrated capability to fulfill federal medical supply requirements through open competition is evidenced by its extensive history of competitively awarded delivery orders with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 5/12/25 |